Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 5;16(9):1250.
doi: 10.3390/ph16091250.

Selenium in Prostate Cancer: Prevention, Progression, and Treatment

Affiliations
Review

Selenium in Prostate Cancer: Prevention, Progression, and Treatment

Jinjiang Jiang et al. Pharmaceuticals (Basel). .

Abstract

Selenium, a trace mineral with various biological functions, has become a focal point in prostate cancer research. This review aims to present a comprehensive overview of selenium's involvement in prostate cancer, covering its impact on prevention, development, treatment, and underlying mechanisms. Observational studies have revealed a link between selenium levels and selenoproteins with prostate cancer progression. However, randomized controlled studies have shown that selenium supplementation does not prevent prostate cancer (HR: 0.95; 95% CI 0.80-1.13). This discrepancy might be attributed to selenoprotein single nucleotide polymorphisms. In the context of combinatorial therapy, selenium has demonstrated promising synergistic potential in the treatment of prostate cancer. Emerging evidence highlights the significant role of selenium and selenoproteins in prostate cancer, encompassing AR signaling, antioxidative properties, cell death, cell cycle regulation, angiogenesis, epigenetic regulation, immunoregulation, epithelial-mesenchymal transformation, and redox signal. In conclusion, selenium's diverse properties make it a promising trace mineral in prostate cancer prevention, development, and treatment and as a platform for exploring novel agents.

Keywords: chemoprevention; progression; prostate cancer; selenium; selenoprotein; therapy.

PubMed Disclaimer

Conflict of interest statement

All the authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of selenium’s biological process in the human body.
Figure 2
Figure 2
Forest plot showing selenium chemoprevention’s property with or without vitamin E in the general population and population with high risk of prostate cancer. Oxidants (with and without selenium) by smoking and health status and all-cause mortality.
Figure 3
Figure 3
Schematic representation of selenium’s roles in the development and progression of prostate cancer.

Similar articles

Cited by

References

    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022;72:7–33. doi: 10.3322/caac.21708. - DOI - PubMed
    1. Zuniga K.B., Chan J.M., Ryan C.J., Kenfield S.A. Diet and lifestyle considerations for patients with prostate cancer. Urol. Oncol. 2020;38:105–117. - PMC - PubMed
    1. Cano-Ibáñez N., Barrios-Rodríguez R., Lozano-Lorca M., Vázquez-Alonso F., Arrabal-Martín M., Triviño-Juárez J.M., Salcedo-Bellido I., Jiménez-Moleón J.J., Olmedo-Requena R. Dietary Diversity and Prostate Cancer in a Spanish Adult Population: CAPLIFE Study. Nutrients. 2020;12:1694. - PMC - PubMed
    1. Ornish D., Weidner G., Fair W.R., Marlin R., Pettengill E.B., Raisin C.J., Dunn-Emke S., Crutchfield L., Jacobs F.N., Barnard R.J., et al. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 2005;174:1065–1069; discussion 1069–1070. doi: 10.1097/01.ju.0000169487.49018.73. - DOI - PubMed
    1. Hamilton R.J. 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times. Cancer Epidemiol. Biomark. Prev. 2022;31:1259–1260. doi: 10.1158/1055-9965.EPI-22-0338. - DOI - PubMed